Cargando…

Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease

Cell cycle proteins are critical to pituitary development, but their contribution to lineage-specific tumorigenesis has not been well-elucidated. Emerging evidence from in vitro human tumor analysis and transgenic mouse models indicates that G1/S-related cell cycle proteins, particularly cyclin E, p...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Takako, Liu, Ning-Ai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096271/
https://www.ncbi.nlm.nih.gov/pubmed/30147673
http://dx.doi.org/10.3389/fendo.2018.00444
_version_ 1783348075191861248
author Araki, Takako
Liu, Ning-Ai
author_facet Araki, Takako
Liu, Ning-Ai
author_sort Araki, Takako
collection PubMed
description Cell cycle proteins are critical to pituitary development, but their contribution to lineage-specific tumorigenesis has not been well-elucidated. Emerging evidence from in vitro human tumor analysis and transgenic mouse models indicates that G1/S-related cell cycle proteins, particularly cyclin E, p27, Rb, and E2F1, drive molecular mechanisms that underlie corticotroph-specific differentiation and development of Cushing disease. The aim of this review is to summarize the literature and discuss the complex role of cell cycle regulation in Cushing disease, with a focus on identifying potential targets for therapeutic intervention in patients with these tumors.
format Online
Article
Text
id pubmed-6096271
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60962712018-08-24 Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease Araki, Takako Liu, Ning-Ai Front Endocrinol (Lausanne) Endocrinology Cell cycle proteins are critical to pituitary development, but their contribution to lineage-specific tumorigenesis has not been well-elucidated. Emerging evidence from in vitro human tumor analysis and transgenic mouse models indicates that G1/S-related cell cycle proteins, particularly cyclin E, p27, Rb, and E2F1, drive molecular mechanisms that underlie corticotroph-specific differentiation and development of Cushing disease. The aim of this review is to summarize the literature and discuss the complex role of cell cycle regulation in Cushing disease, with a focus on identifying potential targets for therapeutic intervention in patients with these tumors. Frontiers Media S.A. 2018-08-10 /pmc/articles/PMC6096271/ /pubmed/30147673 http://dx.doi.org/10.3389/fendo.2018.00444 Text en Copyright © 2018 Araki and Liu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Araki, Takako
Liu, Ning-Ai
Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title_full Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title_fullStr Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title_full_unstemmed Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title_short Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
title_sort cell cycle regulators and lineage-specific therapeutic targets for cushing disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096271/
https://www.ncbi.nlm.nih.gov/pubmed/30147673
http://dx.doi.org/10.3389/fendo.2018.00444
work_keys_str_mv AT arakitakako cellcycleregulatorsandlineagespecifictherapeutictargetsforcushingdisease
AT liuningai cellcycleregulatorsandlineagespecifictherapeutictargetsforcushingdisease